Abstract:1631 Objectives: Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the degeneration of dopaminergic neurons in the substantia nigra of the brain. Stem cell therapy holds great promise as a potential treatment strategy to produce functional neurons from human pluripotent stem cells (PSCs). A strategy of using PSC-derived dopamine neurons modified to express active or inhibitory forms of DREADD (designer receptors exclusively activated by designer drugs) has been developed to evaluate therapeutic potential for PD treatment in the rhesus monkey model. PET radiotracers of [C-11]clozapine and [C-11]raclopride were used to investigate alterations in binding patterns in the endogenous dopamine competition following treatment with the exogenous designer drug clozapine-N-oxide (CNO). Methods: Five rhesus monkeys underwent a unilateral intracarotid artery injection of MPTP targeting the right substantia nigra or putamen. All monkeys received unilateral intracerebral injections of PSCs with guidance from real-time intraoperative magnetic resonance imaging (RT-IMRI) performed in a 3-T GE SIGNA MRI scanner. Daily doses of CNO were administered to the monkeys to activate the DREADDs expressed by the PSC-derived neurons. Four monkeys underwent [C-11]clozapine scans and one monkey underwent a [C-11]raclopride scan on a microPET Focus 220 scanner. Dynamic data were acquired for 90 minutes post-injection of [C-11]clozapine, and a 120 minute bolus+infusion scan of [C-11]raclopride to assess dopamine release during CNO activation. Regions of interest (ROIs) were drawn for the left putamen, right putamen and cerebellum. Time activity curves (TACs) were generated for each ROI for a semi-quantitative comparison of bilateral differences in putamen uptake following treatment. Results: Asymmetries between the left and right putamen were noticed in the PET data for the [C-11]clozapine scans. Two monkeys showed unilateral uptake of radiotracer with no uptake in the right putamen. The remaining showed bilateral uptake of radiotracer in both the left and right putamen following treatment. The [C-11]raclopride results showed bilateral uptake of radiotracer with elevated uptake in the right putamen following the administration of CNO indicating alteration in dopaminergic function. Conclusions: These qualitative results show the potential for evaluation of PSC-derived neuronal function using PET methodologies. The semi-quantitative analysis will be confirmed through histology studies to show the precise location and effectiveness of PSC engraftment at restoring neuronal function.

[18F]fallypride-PET/CT Analysis of the Dopamine D2/D3 Receptor in the Hemiparkinsonian Rat Brain Following Intrastriatal Botulinum Neurotoxin A Injection

The Behavioural Effects and Sept-Hippocampal Cholinergic Activity Changes Caused by Repeated Bont/A Injection on Facial Muscle in Adolescent Mice

Unilateral Whisker Pad Injection of Botulinum Toxin Type a Enhances Spatial Learning in Mice.

Effects of Different Doses of L -Dopa on Rotational Behavior and Amounts of Cells Expressing D2 Receptors in Hemiparkinsonian Rats

Effects of L-dopa on Cells Expressing D2 Receptors and Level of Dopamine Transmitter in Hemiparkinsonian Rats

[A study of microPET for assessing regional cerebral glucose metabolism and the expression of dopamine receptor type 2 in a rat model of Parkinson's disease].

Relation Between Micropet Imaging and Rotational Behavior in a Parkinsonian Rat Model Induced by Medial Forebrain Bundle Axotomy

Effects of intrastriatal injection of the dopamine receptor agonist SKF38393 and quinpirole on locomotor behavior in hemiparkinsonism rats

Evaluation of the early response and mechanism of treatment of Parkinson's disease with L-dopa using 18F-fallypride micro-positron emission tomography scanning

Using PET Methods to Evaluate Induced Pluripotent Stem Cell-Derived Neuronal Function

In Vivo Detection of Monoaminergic Degeneration in Lipopolysaccharide-Induced Rat Model of Parkinson's Disease Using 18F-FP-(+)-DTBZ (18F-AV-133) PET

1-Methyl-4-phenylpyridinium Stereotactic Infusion Completely and Specifically Ablated the Nigrostriatal Dopaminergic Pathway in Rhesus Macaque.

Autoradiographic Study of the Activity of Dopamine D2 Receptor in the Hemiparkinsonian Rat Model

Emission of 50-kHz ultrasonic vocalizations stimulated by antiparkinsonian dopaminomimetic drugs in hemiparkinsonian rats is associated with neuronal activation in subcortical regions that regulate the affective state

Intranigral administration of substance P receptor antagonist attenuated levodopa-induced dyskinesia in a rat model of Parkinson's disease

Rostral Pedunculopontine Nucleus Infusion of M Positive Allosteric Modulator VU0467154 Augments L-DOPA Effects in Hemiparkinsonian Rats

A Rat Model Of Hemidystonia Induced By 3-Nitropropionic Acid

Transfection of the BDNF Gene in the Surviving Dopamine Neurons in Conjunction with Continuous Administration of Pramipexole Restores Normal Motor Behavior in a Bilateral Rat Model of Parkinson's Disease

Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease

Effect of Deep Brain Stimulation on Substantia Nigra Neurons in A Rat Model of Parkinson'S Disease

Treatment of Neuropsychiatric Symptoms in Parkinson's Disease With Botulinum Toxin A: A 12 week Randomized, Double-Blind, Placebo-Controlled Trial